P1124: DUVELISIB IN PATIENTS WITH RELAPSED/REFRACTORY PERIPHERAL T-CELL LYMPHOMA FROM THE PHASE 2 PRIMO TRIAL EXPANSION PHASE: OUTCOMES BY BASELINE HISTOLOGY

Mehta-Shah, N., Jacobsen, E., Luigi Zinzani, P., Zain, J., Mead, M., Casulo, C., Gritti, G., Pinter-Brown, L., Izutsu, K., Waters, S., Brammer, J., Pro, B., & Horwitz, S. (2023). P1124: DUVELISIB IN PATIENTS WITH RELAPSED/REFRACTORY PERIPHERAL T-CELL LYMPHOMA FROM THE PHASE 2 PRIMO TRIAL EXPANSION PHASE: OUTCOMES BY BASELINE HISTOLOGY. HemaSphere, 7(S3), e3891642. https://doi.org/10.1097/01.hs9.0000971392.38916.42
Authors:
Neha Mehta‐Shah
Eric Jacobsen
Pier Luigi Zinzani
Jasmine Zain
Monica Mead
Carla Casulo
Giuseppi Gritti
Lauren Pinter‐Brown
Koji Izutsu
Sheila Waters
Jonathan E. Brammer
Barbara Pro
Steven M. Horwitz
Affiliated Authors:
Barbara Pro
Columbia Affiliation:
Subjects:
Lymphoid Neoplasms (OpenAlex Topic)
Chimeric Antigen Receptor T Cell Therapy (OpenAlex Topic)
elink
Publication Type:
Article
Unique ID:
10.1097/01.hs9.0000971392.38916.42
DOI:
10.1097/01.hs9.0000971392.38916.42
Journal:
HemaSphere
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record

Record Created: